This report delivers exclusive benchmarks on the cost of a new pharmaceutical product launch in today’s market and the timing of 12 key marketing, education and market access activities during and prior to launch. Benchmark data in this report will serve as a reference point for brand and marketing leaders in the budget planning and allocation process to ensure that funding levels are appropriate and launch activities are well-prioritized and well-timed over the three years prior to product launch and during the launch year.
This report delivers benchmarks around the training and accountability of District Sales Managers who oversee launch-related activities in the field. In particular, this report provides benchmarks around the adequate training amount, timing of sales force launch training, assessment of different launch training platforms and measurement of district sales manager accountability.
This benchmarking research identifies current and evolving approaches for development and optimization of global brand websites at launch. It also highlights the critical success factors for fulfilling the diverse needs of key stakeholders, while being mindful of regional differences in culture and regulatory environment.
This study identifies evidence-based benchmarks on the pros and cons of managing multiple products. The study uncovers the proven tactics for efficiently deploying sales and marketing resources to reduce the costliness of launching and promoting multiple products simultaneously.
This study explores the best practices in educating, informing and preparing the marketplace for new diabetes products – through Physician, Patient, and Payer education and publications, advocacy and communication strategies. The study also includes key benchmark metrics, executive insights, and recommendations that Medical Education and Marketing executives can optimize their utilization of current best practices and emerging trends to ensure a successful new product launch.
This study explores the best practices in educating, informing and preparing the marketplace for new oncology products – through Physician, Patient, and Payer education and publications, advocacy and communication strategies.
This research study provided benchmark data on how the world's leading pharmaceutical companies develop global launch strategies, manage launch teams, cultivate thought leader support, integrate marketing activities, and conduct a host of other critical launch activities.
Best Practices, LLC performed an industry-wide benchmark study on multi-phased marketing support for new products across an elite group of high performing pharmaceutical companies. The study includes 16 Blockbuster Product Case Studies and delivers benchmark data on:
- Developing and Deploying Integrated Marketing Support
- Investing for Maximum Impact
- Managing Team Structure, Communication & Transition
- Driving Commercially Focused Drug Development
- Preparing Market for Rapid Product Uptake
- Optimizing Commercial Resources for Launch Success
- Leading and Lagging Indicators for Brand Performance, Marketing Metrics Responsibilities, and Timeline and Competencies
- Marketing Publications Staffing
Product Re-launch - it is the hobgoblin of the pharmaceutical and biotech sector. Few brand leaders ever aspire to this marketing challenge. Yet many find they and their companies must confront re-launch scenarios – or sacrifice hundreds of millions of dollars invested in underperforming products.
A past research initiative probed best practices and lessons learned in successful product re-launches. The study also included two highly successful re-launch case studies: the history and lessons learned from Zithromax and Wellbutrin – two blockbuster products that nearly failed in the marketplace during their initial launches. With interviews and extensive survey data drawn from executives at leading pharmaceutical and biotech companies, our research serves as a guide to achieve an excellent product re-launch.
Whether you are looking for ways to improve the brand and lifecycle management of your portfolio or are facing a re-launch of a product that has not achieved its potential upon initial market entry, our team is ready to assist you by identifying the best re-launch practices from the marketing and brand leaders that have directed their re-launched products to blockbuster success.
Specialty pharmaceutical product marketers strive to effectively allocate their resources among various marketing activities and budget categories. Top executives who are marketing specialty products report that detailing, professional relations and market research have the best levels of ROI.
Past research in this area has benchmarked budget allocation, top pre- and post-launch activities, and primary target audiences. Whether you are trying to expand the market or achieve greater market share, Best Practices, LLC can assist you in determining the best pre- and post-launch strategy for your specialty product.
Pharmaceutical companies spend considerable resources conducting large clinical studies to support the launch of new products or expand indications for currently marketed products. Pharmaceutical companies that can leverage that investment by linking the benefits shown in clinical trials to key products will gain significant advantage in the market.
Best Practices, LLC can help your organization benchmark best-in-class companies and uncover the best strategies and tactics for maximizing the impact of clinical trial results.